
浏览全部资源
扫码关注微信
1.北京市大兴区中医医院 重症医学科, 北京, 102600
2.北京市大兴区中医医院 护理部, 北京, 102600
网络出版日期:2024-09-30,
收稿日期:2024-08-08,
移动端阅览
赵岩, 刘素珀, 王育杨, 等. 1例CKD 5期高钾血症患者的案例报告[DB/OL].中西医结合临床案例库, 2024.
ZHAO Yan, LIU Supo, WANG Yuyang, et al. A Case Report of a CKD Stage 5 Hyperkalemia Patient[DB/OL].Clinical Archives of Integrative Medicine, 2024.
赵岩, 刘素珀, 王育杨, 等. 1例CKD 5期高钾血症患者的案例报告[DB/OL].中西医结合临床案例库, 2024. DOI: 10.12209/CAIM202408080001.
ZHAO Yan, LIU Supo, WANG Yuyang, et al. A Case Report of a CKD Stage 5 Hyperkalemia Patient[DB/OL].Clinical Archives of Integrative Medicine, 2024. DOI: 10.12209/CAIM202408080001.
本文报告1例慢性肾病(Chronic Kidney Disease, CKD)5期患者高钾血症的临床护理经验。该病例特别强调在终末期肾病患者中,病情监测的严密性、治疗调整的紧迫性及护理团队快速反应能力的重要性。通过对患者实施全面的护理评估、精确的护理诊断、个性化的护理计划、细致的护理实施及严格的护理评价,成功地控制高钾血症,减少心脏并发症的风险,并且提高患者的整体护理质量。本报告不仅总结护理过程中的关键干预措施,包括紧急停用可能增加血钾的药物、及时平衡调整电解质、制定低钾饮食计划和提供心理支持,还提供对临床护理实践的深刻见解和建议。通过这一案例,认识到多学科协作在CKD5期高钾血症患者护理中的必要性及个性化护理计划在改善患者预后中的重要作用。本病例报告旨在为临床护理工作者提供参考,以优化对CKD5期高钾血症患者的护理策略。
This article reports the clinical nursing experience of a patient with hyperkalemia in stage 5 chronic kidney disease (CKD). This case emphasizes the importance of strict disease monitoring, urgent treatment adjustments, and rapid response capabilities of nursing teams in patients with end-stage renal disease. By implementing comprehensive nursing assessments, precise nursing diagnoses, personalized nursing plans, meticulous nursing implementation, and strict nursing evaluations on patients, hyperkalemia has been successfully controlled, the risk of cardiac complications has been reduced, and the overall quality of patient care has been improved. This report not only summarizes key intervention measures in the nursing process, including emergency discontinuation of drugs that may increase blood potassium, timely balancing and adjusting electrolytes, developing a low potassium diet plan, and providing psychological support, but also provides profound insights and recommendations for clinical nursing practice. Through this case, we have realized the necessity of multidisciplinary collaboration in the care of CKD5 stage hyperkalemia patients and the important role of personalized care plans in improving patient prognosis. This case report aims to provide reference for clinical nursing workers to optimize nursing strategies for CKD5 stage hyperkalemia patients.
CKD5期高钾血症案例报告护理
CKD5 periodhyperkalemiacase reportnursing
中华医学会肾脏病学分会专家组. 中国慢性肾脏病患者血钾管理实践专家共识[J]. 中华肾脏病杂志, 2020, 36(10): 781-792.
Chinese Society of Nephrology expert group. Expert consensus on the management of serum potassium in chronic kidney disease patients in China[J]. Chin J Nephrol, 2020, 36(10): 781-792.(in Chinese)
刘东伟, 王奕雪, 刘章锁. 慢性肾脏病患者高钾血症的防与治[J]. 中华医学杂志, 2021, 101(42): 3443-3446.
LIU D W, WANG Y X, LIU Z S. Prevention and treatment of hyperkalemia in chronic kidney disease[J]. Natl Med J China, 2021, 101(42): 3443-3446.(in Chinese)
张静姝, 刘学政. 慢性肾脏病患者高钾血症二例[J]. 中国临床案例成果数据库, 2021, 03(01):E285-E285.
ZHANG J S, LIU X Z. Hyperkalemia 2 patients with chronic kidney disease [J]. Journal of Chinese clinical results of case database, 2021, 03 (01) : E285 - E285.(in Chinese)
RHEE C M, AHMADI S F, KOVESDY C P, et al. Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials[J]. J Cachexia Sarcopenia Muscle, 2018, 9(2): 235-245.
KALAITZIDIS R G, ELISAF M S. Treatment of hypertension in chronic kidney disease[J]. Curr Hypertens Rep, 2018, 20(8): 64.
LÖFMAN I, SZUMMER K, DAHLSTRÖM U, et al. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction[J]. Eur J Heart Fail, 2017, 19(12): 1606-1614.
BURNIER M, DAMIANAKI A. Hypertension as cardiovascular risk factor in chronic kidney disease[J]. Circ Res, 2023, 132(8): 1050-1063.
MITROFANOVA A, MERSCHER S, FORNONI A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease[J]. Nat Rev Nephrol, 2023, 19(10): 629-645.
KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES CKD WORK GROUP. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int, 2024, 105(4S): S117-S314.
HUTCHESON J D, GOETTSCH C. Cardiovascular calcification heterogeneity in chronic kidney disease[J]. Circ Res, 2023, 132(8): 993-1012.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621